
Human Isoform 6 of erbB-2 753-760, VLRENTSPK
Description
About Human Isoform 6 of erbB-2 753-760, VLRENTSPK
The Human ErbB-2 receptor tyrosin-protein kinase (Isoform 6) Peptide (IEDB: 69734) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The ErbB-2 receptor tyrosin-protein kinase Peptide, H-VLRENTSPK-OH (Uniprot: P04626 aa: 753-760) from JPT is produced under strict quality control and quality management.
Human Isoform 6 of erbB-2 753-760, VLRENTSPK - Specifications
- Peptide sequence: H-VLRENTSPK-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Melanoma, Cancer
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Isoform 6 of erbB-2 753-760, VLRENTSPK
References:
Read References with JPT’s Antigen Peptides
Human Isoform 6 of erbB-2 753-760, VLRENTSPK has been described in:
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma., Elife, 2020 (PMID: 32314731)
A pilot trial of vaccination with Carcinoembryonic antigen and Her2/neu peptides in advanced colorectal cancer., Int J Cancer, 2022 (PMID: 34480368)
High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera., Proteomics, 2016 (PMID: 26992070)
Documentation
Documentation for Human Isoform 6 of erbB-2 753-760, VLRENTSPK
Properties
Properties of Human Isoform 6 of erbB-2 753-760, VLRENTSPK
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Cancer, Melanoma |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | ErbB-2 receptor tyrosin-protein kinase |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Isoform 6 of erbB-2 753-760, VLRENTSPK
Information | Values |
---|---|
Sequence: | H-VLRENTSPK-OH |
Specifications: | 9mer peptide as TFA salt |